Simplex Trading’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-22
Closed -$48 10257
2023
Q2
$0 Buy
+22
New +$46 ﹤0.01% 10313
2023
Q1
Sell
-15,716
Closed -$31.1K 10526
2022
Q4
$29K Sell
15,716
-242,569
-94% -$605K ﹤0.01% 6528
2022
Q3
$663K Buy
+258,285
New +$643K ﹤0.01% 3137
2022
Q2
Sell
-1,426
Closed -$3.11K 11482
2022
Q1
$4K Sell
1,426
-4,758
-77% -$17.9K ﹤0.01% 9627
2021
Q4
$27K Sell
6,184
-19,016
-75% -$90.2K ﹤0.01% 8053
2021
Q3
$182K Buy
25,200
+84
+0.3% +$463 ﹤0.01% 5746
2021
Q2
$171K Buy
+25,116
New +$203K ﹤0.01% 5946
2020
Q4
Sell
-1,515
Closed -$8.91K 9300
2020
Q3
$8K Sell
1,515
-11,004
-88% -$54.5K ﹤0.01% 6926
2020
Q2
$65K Buy
12,519
+8,066
+181% +$35.8K ﹤0.01% 5258
2020
Q1
$14K Sell
4,453
-29,187
-87% -$108K ﹤0.01% 6254
2019
Q4
$135K Buy
33,640
+26,484
+370% +$91.9K ﹤0.01% 4184
2019
Q3
$30K Buy
7,156
+7,124
+22,263% +$28.5K ﹤0.01% 5505
2019
Q2
$0 Buy
+32
New +$152 ﹤0.01% 8016
2019
Q1
Sell
-1,697
Closed -$11K 8084
2018
Q4
$8K Sell
1,697
-3,079
-64% -$23.4K ﹤0.01% 6009
2018
Q3
$46K Buy
+4,776
New +$48.2K ﹤0.01% 5253
2018
Q1
Sell
-4,429
Closed -$65.9K 7076
2017
Q4
$79K Sell
4,429
-31,889
-88% -$665K ﹤0.01% 2013
2017
Q3
$911K Buy
36,318
+11,826
+48% +$275K 0.04% 412
2017
Q2
$590K Buy
+24,492
New +$541K 0.03% 570
2015
Q1
Sell
-8
Closed 5773
2014
Q4
$0 Buy
+8
New +$191 ﹤0.01% 4658

Simplex Trading's PRTK Position: Q3 2023 in Review

Simplex Trading sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 22 shares — an estimated $48 sold.

Simplex Trading first reported a position in PRTK in Q4 2014 and held it in 19 quarters. The position peaked at $911K in Q3 2017. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.

  • Simplex Trading reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • Simplex Trading sold 22 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $48.
  • Simplex Trading first reported a position in Paratek Pharmaceuticals, Inc. in Q4 2014 and held it in 19 quarters.
  • Simplex Trading's Paratek Pharmaceuticals, Inc. position peaked at $911K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.

Based on Simplex Trading's 13F filing for Q3 2023, filed 1 Nov 2023.